Risk for Acute MI Not Increased With Two-Dose HepB-CpG Vaccine
Noninferiority study shows no increased risk for acute MI with two-dose HepB-CpG vaccine versus three-dose HepB-alum vaccine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.